Literature DB >> 18795325

End-stage kidney disease: gains of chromosomes 7 and 17 and loss of Y chromosome in non-neoplastic tissue.

Ondrej Hes1, Radek Síma, Jana Nemcová, Milan Hora, Stela Bulimbasic, Dmitry V Kazakov, Tomás Urge, Tomás Reischig, Miroslav Dvorák, Michal Michal.   

Abstract

The aim of this study was to determine the copy number changes of chromosomes 7, 17, 3p, and Y in a non-neoplastic tubular epithelium in end-stage kidney disease (ESKD). Seventeen kidneys from 11 patients with ESKD were retrieved from the archive files. Non-neoplastic kidney tissue in these cases was examined separately. Tissues containing papillary adenomas (PA), clear (CRCC) and papillary renal cell carcinomas (PRCC), and myxoid liposarcoma (LPS) were examined using the same probes and compared with non-neoplastic tissue. Tubular changes in the kidney parenchyma were classified into three types: (1) The vast majority of tubules were entirely atrophic; (2) Several tubules were hyperplastic, i.e., tubules with undifferentiated large epithelial cells, in which it was impossible to establish the specific type of a renal tubulus; (3) Dysplastic tubules were dilated, sometimes wrinkled. The basal membranes were lined by large eosinophilic epithelial cells with polymorphic nuclei and pseudostratification. Nucleoli were clearly visible. These tubular changes were multifocal with a haphazard distribution within the atrophic parenchyma. PA were detected in nine patients, of whom eight patients also revealed an additional tumor type(s) (4x CRCC, 3x PRCC, 1x PRCC, and CRCC). One patient had a CRCC only, another had a combination of PRCC and LPS. Chromosomal abnormalities were found in the second and third group of tubular changes, i.e., in hyperplastic and dysplastic tubules. Trisomy of chromosome 7 was detected in six cases, whereas trisomy of chromosome 17 in eight cases. A combination of both trisomies was found in five cases. Loss of chromosome Y was found in two cases. Fluorescence in situ hybridization on tissues containing papillary adenomas, renal cell carcinomas, and liposarcoma revealed expected results, i.e., trisomy of chromosomes 7 and 17 in all PAs and PRCC. No gains were present in CRCC and LPS. Loss of Y was found in six PA, five PRCC, and one LPS; loss of X was found in two CRCCs. We suggest that chromosomal changes typical of the papillary renal cell lesions, i.e., trisomies of chromosomes 7 and 17, are very frequent in non-neoplastic parenchyma of the end-stage kidney, and they have a tendency to a multifocal occurrence.

Entities:  

Mesh:

Year:  2008        PMID: 18795325     DOI: 10.1007/s00428-008-0661-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  20 in total

1.  Premalignant lesions of the kidney share the same genetics changes as conventional renal cell carcinoma.

Authors:  S Pehlivan; M Koyuncuoglu; M Pehlivan; S Izzetoglu; Y Mater; M Cabuk; Z Kirkali
Journal:  World J Urol       Date:  2003-12-20       Impact factor: 4.226

2.  Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.

Authors:  Satish K Tickoo; Mariza N dePeralta-Venturina; Lara R Harik; Heath D Worcester; Mohamed E Salama; Andrew N Young; Holger Moch; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2006-02       Impact factor: 6.394

3.  Trisomy 7 in non-neoplastic tubular epithelial cells of the kidney.

Authors:  S Knuutila; M L Larramendy; P Elfving; W el-Rifai; A Miettinen; F Mitelman
Journal:  Hum Genet       Date:  1995-02       Impact factor: 4.132

4.  Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.

Authors:  M D Hughson; S Bigler; K Dickman; G Kovacs
Journal:  Mod Pathol       Date:  1999-03       Impact factor: 7.842

Review 5.  The Heidelberg classification of renal cell tumours.

Authors:  G Kovacs; M Akhtar; B J Beckwith; P Bugert; C S Cooper; B Delahunt; J N Eble; S Fleming; B Ljungberg; L J Medeiros; H Moch; V E Reuter; E Ritz; G Roos; D Schmidt; J R Srigley; S Störkel; E van den Berg; B Zbar
Journal:  J Pathol       Date:  1997-10       Impact factor: 7.996

6.  Gains of chromosomes 7, 17, 12, 16, and 20 and loss of Y occur early in the evolution of papillary renal cell neoplasia: a fluorescent in situ hybridization study.

Authors:  Matteo Brunelli; John N Eble; Shaobo Zhang; Guido Martignoni; Liang Cheng
Journal:  Mod Pathol       Date:  2003-10       Impact factor: 7.842

7.  Clonal origin of multifocal renal cell carcinoma as determined by microsatellite analysis.

Authors:  Kerstin Junker; Katharina Thrum; Andreas Schlichter; Gabriele Müller; Winfried Hindermann; Joerg Schubert
Journal:  J Urol       Date:  2002-12       Impact factor: 7.450

8.  Trisomy 7 and trisomy 10 characterize subpopulations of tumor-infiltrating lymphocytes in kidney tumors and in the surrounding kidney tissue.

Authors:  P Dal Cin; M S Aly; J Delabie; J L Ceuppens; S Van Gool; B Van Damme; L Baert; H Van Poppel; H Van den Berghe
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

9.  Renal cell carcinoma in an end-stage kidney of a patient with a functional transplant: cytogenetic and molecular genetic findings.

Authors:  M D Hughson; A M Meloni; F G Silva; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1996-07-01

10.  EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization.

Authors:  H Moch; G Sauter; T C Gasser; L Bubendorf; J Richter; J C Presti; F M Waldman; M J Mihatsch
Journal:  J Pathol       Date:  1998-04       Impact factor: 7.996

View more
  4 in total

1.  Acquired cystic disease-associated renal cell carcinoma with gain of chromosomes 3, 7, and 16, gain of chromosome X, and loss of chromosome Y.

Authors:  Naoto Kuroda; Tomoyuki Shiotsu; Ondrej Hes; Michal Michal; Taro Shuin; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

2.  Acquired cystic disease-associated renal cell carcinoma: an immunohistochemical and fluorescence in situ hybridization study.

Authors:  Naoto Kuroda; Motoki Yamashita; Yoshiyuki Kakehi; Ondrej Hes; Michal Michal; Gang-Hong Lee
Journal:  Med Mol Morphol       Date:  2011-12-17       Impact factor: 2.309

3.  Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.

Authors:  Jun Zhou; Xiaoqun Yang; Luting Zhou; Peipei Zhang; Chaofu Wang
Journal:  Dis Markers       Date:  2019-10-13       Impact factor: 3.434

4.  Y-chromosome loss is frequent in male renal tumors.

Authors:  Franziska Büscheck; Christoph Fraune; Seyedehmina Garmestani; Ronald Simon; Martina Kluth; Claudia Hube-Magg; Kathrin Ketterer; Christian Eichelberg; Doris Höflmayer; Frank Jacobsen; Corinna Wittmer; Waldemar Wilczak; Guido Sauter; Margit Fisch; Till Eichenauer; Michael Rink
Journal:  Ann Transl Med       Date:  2021-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.